AKT1 and neoplasm: Recently, accumulating studies about PI3K (phosphoinositide 3-kinases) inhibitors have enriched tumor treatment methods due to the indication of the relationship between the PI3K/Akt/mTOR pathway and drug resistance and prognosis of tumor.